Evidence map›Paper›PMID 41701800›Full record

ArticlePLoS computational biology2026

MENDELSEEK: An algorithm that predicts mendelian genes and elucidates what makes them special.

Hongyi Zhou, Brice Edelman, Jeffrey Skolnick

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hongyi ZhouCenter for the Study of Systems Biology, School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
Brice EdelmanCenter for the Study of Systems Biology, School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
Jeffrey SkolnickCenter for the Study of Systems Biology, School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-1877-4958

Funding

Purchase of a GPU cluster for deep learning applications in protein-protein interaction and supercomplex prediction and biochemical literature annotation.R35GM118039 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI JEFFREY SKOLNICK · 2016 to 2026
$5.8M
NIGMS NIH HHS R35 GM118039
6 · The paper itself

Abstract

Although individual Mendelian diseases-those caused by a single gene-are rare, their collective disease burden is substantial. Identifying the causal gene for each condition is essential for accurate diagnosis and effective treatment. Yet, despite decades of research, the genetic basis of more than half of all known Mendelian diseases remains unresolved. To address this gap, we introduce MENDELSEEK, a machine learning framework that predicts Mendelian genes by integrating residue variation scores with pathway participation, Gene Ontology processes, and protein language model features. In benchmarking across 16,946 human genes with 10-fold cross-validation, MENDELSEEK achieved an AUC of 0.869 and an AUPR of 0.737-substantially outperforming the next best methods, ENTPRISE+ENTPRISE-X (AUC 0.781; AUPR 0.626), and REVEL (AUC 0.585; AUPR 0.401). When applied to the full set of 17,858 human genes, MENDELSEEK predicted 1,277 novel Mendelian gene candidates with precision greater than 0.7. Analysis further revealed that Mendelian genes engage in significantly more protein-protein interactions than non-Mendelian genes and are evolutionarily ancient. Together, these results highlight MENDELSEEK as a major advance over existing methods, offering new insights into the biochemical features that distinguish Mendelian from non-Mendelian genes.

Indexed as

AlgorithmsComputational BiologyGenetic Diseases, InbornMachine LearningDatabases, GeneticGene OntologyGenetic Predisposition to DiseaseHumansPrediction Algorithms

Identifiers

PMID41701800
PMCPMC12956125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.